Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bolt Biotherapeutics (BOLT) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Bolt Biotherapeutics (BOLT) over the last 5 years, with Q3 2025 value amounting to 0.07.

  • Bolt Biotherapeutics' Asset Utilization Ratio fell 1174.09% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year decrease of 1174.09%. This contributed to the annual value of 0.06 for FY2024, which is 4588.06% up from last year.
  • Bolt Biotherapeutics' Asset Utilization Ratio amounted to 0.07 in Q3 2025, which was down 1174.09% from 0.05 recorded in Q2 2025.
  • Over the past 5 years, Bolt Biotherapeutics' Asset Utilization Ratio peaked at 0.08 during Q3 2024, and registered a low of 0.0 during Q1 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.04, with a median of 0.04 in 2023.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 184482.22% in 2022, then tumbled by 4757.83% in 2025.
  • Over the past 5 years, Bolt Biotherapeutics' Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then soared by 516.03% to 0.02 in 2022, then soared by 94.16% to 0.05 in 2023, then surged by 56.59% to 0.07 in 2024, then increased by 0.44% to 0.07 in 2025.
  • Its Asset Utilization Ratio stands at 0.07 for Q3 2025, versus 0.05 for Q2 2025 and 0.04 for Q1 2025.